Enfortumab vedotin-ejfv 是一种anti-Nectin-4 antibody-drug conjugate，用于尿路上皮癌的研究。
| 生物活性 | Enfortumab vedotin-ejfv is ananti-Nectin-4 antibody-drug conjugatefor the management of urothelial carcinoma[1]. |
体外研究
(In Vitro) | Enfortumab vedotin-ejfv is a fully human IgG1-kappa antibody conjugated to the microtubule-disrupting agent, monomethyl auristatin E (MMAE), via a protease-cleavable maleimidocaproyl valine-citrulline linker (SGD-1006)[2].
|
| Clinical Trial | |
| 性状 | |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com